Zoetis (ZTS) Net Margin (2012 - 2026)

Zoetis' (ZTS) quarterly Net Margin came in at 26.57% in Q1 2026, down 82.0% year-on-year from 147.61% in Q1 2025, and up 5.18% on a QoQ basis from 25.26% in Q4 2025.

Zoetis (ZTS) Net Margin (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Net Margin data on file, last reported at 26.57% in Q1 2026.

  • On a quarterly basis, Net Margin fell 82.0% year-over-year to 26.57% in Q1 2026; TTM through Mar 2026 was 27.79%, a 82.0% increase from a year earlier, with the FY2025 full-year figure at 28.23%, up 127.0% from the prior year.
  • Net Margin for Q1 2026 stood at 26.57%, up from 25.26% in the prior quarter.
  • Over the last five years, Net Margin for ZTS reached as high as 30.73% in Q2 2023 and fell as low as 22.55% in Q4 2022.
  • Historically, Net Margin has averaged 27.09% across 5 years, with a median of 27.35% in 2024.
  • Across the five-year window, Net Margin jumped 495 bps in 2023 and slumped 430 bps in 2024, its largest moves.
  • Year by year, Net Margin stood at 22.55% in 2022, then increased by 5 bps to 23.63% in 2023, then advanced by 6 bps to 25.08% in 2024, then advanced by 1 bps to 25.26% in 2025, then increased by 5 bps to 26.57% in 2026.
  • Per Business Quant data, the three most recent Net Margin figures were 26.57% in Q1 2026, 25.26% in Q4 2025, and 30.04% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -21.19%

Historic Data

Download Data
DateValue
Mar 31, 2026 26.57%
Dec 31, 2025 25.26%
Sep 30, 2025 30.04%
Jun 30, 2025 29.19%
Mar 31, 2025 27.39%
Dec 31, 2024 25.08%
Sep 30, 2024 28.98%
Jun 30, 2024 26.43%
Mar 31, 2024 27.35%
Dec 31, 2023 23.63%
Sep 30, 2023 27.71%
Jun 30, 2023 30.73%
Mar 31, 2023 27.55%
Dec 31, 2022 22.55%
Sep 30, 2022 26.37%
Jun 30, 2022 25.78%
Mar 31, 2022 29.91%
Dec 31, 2021 21.00%
Sep 30, 2021 27.74%
Jun 30, 2021 26.23%